Confronto

Buserelin vs. Triptorelin

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

57982-77-1

57773-63-4

Peso molecolare

1239.42 g/mol

1311.45 g/mol

Emivita

nessun dato

3 h

Sequenza

nessun dato

pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2

Meccanismo d'azione

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Triptorelin

Triptorelin binds with high affinity to the GnRH receptor in the pituitary. After initial stimulation of LH and FSH secretion (flare phase, about 1-2 weeks), receptor desensitisation follows with consecutive gonadotropin suppression. This results in a reversible chemical castration: in men testosterone, in women oestrogen suppression to the postmenopausal range.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Buserelin	Triptorelin
Germania	Su prescrizione	Su prescrizione
Stati Uniti	Non approvato	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Buserelin and Triptorelin?: Buserelin is classified as "Ricerca (altro)", while Triptorelin is classified as "Ricerca (altro)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Triptorelin: Synthetic decapeptide GnRH agonist with increased affinity over native gonadotropin-releasing hormone. FDA- and EMA-approved since the 1980s for prostate cancer, endometriosis and precocious puberty. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Triptorelin?: The highest available evidence level is "RCT sull'uomo" for Buserelin and "RCT sull'uomo" for Triptorelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Triptorelin in Germany and the United States?: Germania: Buserelin — Su prescrizione, Triptorelin — Su prescrizione. Stati Uniti: Buserelin — Non approvato, Triptorelin — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Triptorelin

Germania

Su prescrizione

Stati Uniti

Non approvato

Su prescrizione

Frequently asked questions

What is the difference between Buserelin and Triptorelin?

Buserelin is classified as "Ricerca (altro)", while Triptorelin is classified as "Ricerca (altro)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Triptorelin: Synthetic decapeptide GnRH agonist with increased affinity over native gonadotropin-releasing hormone. FDA- and EMA-approved since the 1980s for prostate cancer, endometriosis and precocious puberty. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Triptorelin?

The highest available evidence level is "RCT sull'uomo" for Buserelin and "RCT sull'uomo" for Triptorelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Triptorelin in Germany and the United States?

Germania: Buserelin — Su prescrizione, Triptorelin — Su prescrizione. Stati Uniti: Buserelin — Non approvato, Triptorelin — Su prescrizione. These are factual summaries with source and review date on the individual pages.